AtriCure, Inc. (ATRC) Posts Q3 EPS Loss of $0.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.30 +2.83%
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ORPB, PBCO, SICP, More
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AtriCure Inc. (ATRC) PT Raised to $68 at Citizens on Upside to Current Forecasts
- Consumer Portfolio Services (CPSS) Reports Q3 EPS of $0.30
- Eagle Financial Services, Inc. (EFSI) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
